Normal mode-based approaches in receptor ensemble docking.
暂无分享,去创建一个
[1] S. Kim,et al. "Soft docking": matching of molecular surface cubes. , 1991, Journal of molecular biology.
[2] M. Zacharias,et al. Accounting for global protein deformability during protein-protein and protein-ligand docking. , 2005, Biochimica et biophysica acta.
[3] X. Barril,et al. Unveiling the full potential of flexible receptor docking using multiple crystallographic structures. , 2005, Journal of medicinal chemistry.
[4] B. Shoichet,et al. Soft docking and multiple receptor conformations in virtual screening. , 2004, Journal of medicinal chemistry.
[5] S. Ozkan,et al. A flexible docking scheme to explore the binding selectivity of PDZ domains , 2010, Protein science : a publication of the Protein Society.
[6] D. Pérahia,et al. Normal mode analysis as a prerequisite for drug design: Application to matrix metalloproteinases inhibitors , 2006, FEBS letters.
[7] Olivier Sperandio,et al. How to choose relevant multiple receptor conformations for virtual screening: a test case of Cdk2 and normal mode analysis , 2010, European Biophysics Journal.
[8] I. Bahar,et al. Coarse-grained normal mode analysis in structural biology. , 2005, Current opinion in structural biology.
[9] S. Teague. Implications of protein flexibility for drug discovery , 2003, Nature Reviews Drug Discovery.
[10] Claudio N. Cavasotto and Narender Singh. Docking and High Throughput Docking: Successes and the Challenge of Protein Flexibility , 2008 .
[11] Claudio N. Cavasotto,et al. Representing receptor flexibility in ligand docking through relevant normal modes. , 2005, Journal of the American Chemical Society.
[12] A. Leach,et al. Ligand docking to proteins with discrete side-chain flexibility. , 1994, Journal of molecular biology.
[13] J. W. Humberston. Classical mechanics , 1980, Nature.
[14] Richard A. Lewis,et al. Lessons in molecular recognition: the effects of ligand and protein flexibility on molecular docking accuracy. , 2004, Journal of medicinal chemistry.
[15] Holger Gohlke,et al. Target flexibility: an emerging consideration in drug discovery and design. , 2008, Journal of medicinal chemistry.
[16] C. Humblet,et al. Modeling G protein‐coupled receptors for structure‐based drug discovery using low‐frequency normal modes for refinement of homology models: Application to H3 antagonists , 2010, Proteins.
[17] M. Zacharias,et al. Protein-ligand docking accounting for receptor side chain and global flexibility in normal modes: evaluation on kinase inhibitor cross docking. , 2008, Journal of medicinal chemistry.
[18] H. Wolfson,et al. FiberDock: Flexible induced‐fit backbone refinement in molecular docking , 2010, Proteins.
[19] Erin S. Bolstad,et al. In pursuit of virtual lead optimization: The role of the receptor structure and ensembles in accurate docking , 2008, Proteins.
[20] H. Scheraga,et al. Monte Carlo-minimization approach to the multiple-minima problem in protein folding. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[21] G. Phillips,et al. Optimization and evaluation of a coarse-grained model of protein motion using x-ray crystal data. , 2006, Biophysical journal.
[22] Claudio N. Cavasotto,et al. Ligand docking and structure-based virtual screening in drug discovery. , 2007, Current topics in medicinal chemistry.
[23] Claudio N. Cavasotto,et al. Scalaradial, a Dialdehyde‐Containing Marine Metabolite That Causes an Unexpected Noncovalent PLA2 Inactivation , 2007, Chembiochem : a European journal of chemical biology.
[24] W. L. Jorgensen. The Many Roles of Computation in Drug Discovery , 2004, Science.
[25] R. Glen,et al. Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. , 1995, Journal of molecular biology.
[26] Claudio N. Cavasotto,et al. Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening. , 2008, Journal of medicinal chemistry.
[27] Ivet Bahar,et al. Computational Generation inhibitor-Bound Conformers of P38 Map Kinase and Comparison with Experiments , 2011, Pacific Symposium on Biocomputing.
[28] M. Levitt,et al. Protein normal-mode dynamics: trypsin inhibitor, crambin, ribonuclease and lysozyme. , 1985, Journal of molecular biology.
[29] Claudio N. Cavasotto,et al. Homology modeling in drug discovery: current trends and applications. , 2009, Drug discovery today.
[30] Claudio N. Cavasotto,et al. Ligand-Steered Modeling and Docking: A Benchmarking Study in Class A G-Protein-Coupled Receptors , 2010, J. Chem. Inf. Model..
[31] Ivet Bahar,et al. Anisotropic network model: systematic evaluation and a new web interface , 2006, Bioinform..
[32] Pieter F. W. Stouten,et al. Fast prediction and visualization of protein binding pockets with PASS , 2000, J. Comput. Aided Mol. Des..
[33] Campbell McInnes,et al. Virtual screening strategies in drug discovery. , 2007, Current opinion in chemical biology.
[34] K. Hinsen. Analysis of domain motions by approximate normal mode calculations , 1998, Proteins.
[35] V. Pande,et al. Can conformational change be described by only a few normal modes? , 2006, Biophysical journal.
[36] Erik Lindahl,et al. Refinement of docked protein–ligand and protein–DNA structures using low frequency normal mode amplitude optimization , 2005, Nucleic acids research.
[37] Ruth Nussinov,et al. An integrated suite of fast docking algorithms , 2010, Proteins.
[38] Tirion,et al. Large Amplitude Elastic Motions in Proteins from a Single-Parameter, Atomic Analysis. , 1996, Physical review letters.
[39] Maria A Miteva,et al. Structure-based virtual ligand screening: recent success stories. , 2009, Combinatorial chemistry & high throughput screening.
[40] David Perahia,et al. Activation of the ghrelin receptor is described by a privileged collective motion: a model for constitutive and agonist-induced activation of a sub-class A G-protein coupled receptor (GPCR). , 2010, Journal of molecular biology.
[41] Peter A. Kollman,et al. AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules , 1995 .
[42] Claudio N. Cavasotto,et al. Protein flexibility in ligand docking and virtual screening to protein kinases. , 2004, Journal of molecular biology.
[43] Mark Gerstein,et al. Normal mode analysis of macromolecular motions in a database framework: Developing mode concentration as a useful classifying statistic , 2002, Proteins.
[44] Adrian A Canutescu,et al. Cyclic coordinate descent: A robotics algorithm for protein loop closure , 2003, Protein science : a publication of the Protein Society.
[45] F. J. Luque,et al. Protein flexibility and ligand recognition: challenges for molecular modeling. , 2011, Current topics in medicinal chemistry.
[46] Brian K. Shoichet,et al. Virtual screening of chemical libraries , 2004, Nature.
[47] Rommie E. Amaro,et al. Emerging methods for ensemble-based virtual screening. , 2010, Current topics in medicinal chemistry.
[48] Claudio N. Cavasotto,et al. Conformational Sampling of Protein Flexibility in Generalized Coordinates: Application to Ligand Docking , 2005 .
[49] C. Cavasotto,et al. The binding mode of petrosaspongiolide M to the human group IIA phospholipase A(2): exploring the role of covalent and noncovalent interactions in the inhibition process. , 2009, Chemistry.
[50] Ruben Abagyan,et al. Consistent Improvement of Cross-Docking Results Using Binding Site Ensembles Generated with Elastic Network Normal Modes , 2009, J. Chem. Inf. Model..
[51] X. Barril,et al. Incorporating protein flexibility into docking and structure-based drug design , 2006, Expert opinion on drug discovery.
[52] R. Jernigan,et al. Anisotropy of fluctuation dynamics of proteins with an elastic network model. , 2001, Biophysical journal.
[53] A. Atilgan,et al. Direct evaluation of thermal fluctuations in proteins using a single-parameter harmonic potential. , 1997, Folding & design.
[54] H. Gohlke,et al. Large‐scale comparison of protein essential dynamics from molecular dynamics simulations and coarse‐grained normal mode analyses , 2010, Proteins.
[55] A. Anderson. The process of structure-based drug design. , 2003, Chemistry & biology.
[56] I. Bahar,et al. Normal mode analysis of biomolecular structures: functional mechanisms of membrane proteins. , 2010, Chemical reviews.
[57] M. Karplus,et al. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .
[58] Ivet Bahar,et al. Elastic network models for understanding biomolecular machinery: from enzymes to supramolecular assemblies , 2005, Physical biology.